{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.12.1076","meta":{"versionId":"14","lastUpdated":"2019-02-26T22:31:47.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2019-02-26"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1076","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.12.1076"}],"version":"20170504","name":"PneumocystisJiroveciPneumoniaPCPProphylaxis","title":"Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis","status":"active","experimental":false,"date":"2017-05-04T01:00:13-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This value set contains concepts that represent Pneumocystis jiroveci pneumonia (PCP) prophylaxis medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Order.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable. Includes only relevant concepts associated with trimethoprim-sulfamethoxazole, dapsone, atovaquone, and pentamidine isethionate.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; PCP prophylaxis medications in combination with other medications.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1076"]}]},"expansion":{"identifier":"urn:uuid:f64d944b-abce-4537-a6db-fda7a303b232","timestamp":"2023-12-11T02:34:12-05:00","total":11,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"142118","display":"sulfamethoxazole 100 MG / trimethoprim 20 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197557","display":"dapsone 100 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197558","display":"dapsone 25 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"198334","display":"sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"198335","display":"sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"308429","display":"atovaquone 150 MG/ML Oral Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"313134","display":"sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"313137","display":"sulfamethoxazole 80 MG/ML / trimethoprim 16 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"607295","display":"dapsone 0.05 MG/MG Topical Gel"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"861597","display":"pentamidine isethionate 50 MG/ML Inhalation Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"861601","display":"pentamidine isethionate 300 MG Injection"}]}}